Biotech Innovation Company Aditxt to Establish State-of-the-Art Immune Monitoring Center in Richmond, VA
AditxtScore™ Center is the first of a planned immune monitoring network and will initially monitor COVID-19 immunity status;
New facility expects to target more than 300 jobs over three years to the area
Mountain View, CA and Richmond, VA – May 3, 2021 Aditxt (Aditx Therapeutics, Inc.) (Nasdaq: ADTX), a biotech innovation company focused on improving the health of the immune system, today announced plans to build a high-capacity AditxtScore™ Center in Richmond, VA in the second half of 2021. Aditxt is targeting a capital investment of $31.5 million over three years to scale up its state-of-the-art immune monitoring center, including projected new jobs, laboratory equipment, and construction. The announcement was made at a joint press conference with Governor Ralph Northam, Richmond Mayor Levar Stoney and other local business executives and political officials.
Virginia
United-states
Richmond
Mountain-view
Commonwealth-of-virginia
Amro-albanna
Levar-stoney
Ralph-northam
Aditxt-aditx-therapeutics-inc-nasdaq
Northam-administration
Aditxt-immune-monitoring-center
Virginia-community-college-system
Immunity research firm Aditxt to invest $31.5M in new downtown lab
May 4, 2021
Gov. Ralph Northam presents a Virginia flag to Aditxt CEO Amro Albanna alongside Richmond Mayor Levar Stoney at an announcement about a new lab. (
Jonathan Spiers photo)
A Silicon Valley-based company that has developed a way to track immunity to diseases like COVID-19 is building a new lab at the VA Bio+Tech Park, where another multimillion-dollar project is getting another look.
Aditx Therapeutics, or Aditxt for short, announced Monday it will invest $31.5 million over three years to develop an immune monitoring center in the Bio+Tech 8 building at 737 N. Fifth St. on the downtown campus.
New-york
United-states
Henrico-county
Virginia
Richmond
Amro-albanna
Jeff-bourne
Jonathan-spiers
Levar-stoney
Chandra-briggman
Ralph-northam
Phlow-corp
Aditxt to build state-of-the-art facility in Richmond, creating 300+ new jobs
Published Tuesday, May. 4, 2021, 6:35 am
Join AFP s 100,000+ followers on Facebook
Purchase a subscription to AFP
Subscribe to AFP podcasts on iTunes and Spotify
News, press releases, letters to the editor: augustafreepress2@gmail.com
(© josephsjacobs – stock.adobe.com)
Aditxt will establish its first high-capacity AditxtScore™ Center in the City of Richmond in the second half of 2021.
Aditxt plans to create more than 300 new jobs and targets making a capital investment of $31.5 million over three years to scale up its state-of-the-art immune monitoring center, including projected new jobs, laboratory equipment, and construction.
“The Richmond region has emerged as a hub for cutting-edge biotech companies, and this thriving industry will be bolstered by the addition of Aditxt’s Immune Monitoring Center,” Gov. Ralph Northam said. “The Virginia Bio+Tech Park is an ideal location for
Virginia
United-states
City-of-richmond
Richmond
Commonwealth-of-virginia
Amro-albanna
Jeff-bourne
Jennifer-mcclellan
Chandra-briggman
Ralph-northam
Levar-stoney
A-donald-mceachin
vimarsana © 2020. All Rights Reserved.